Page last updated: 2024-12-11

fk 352

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

FK 352: a pyrazolopyridine derivative; adenosine-1 receptor antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6442241
SCHEMBL ID3072324
SCHEMBL ID2829060
MeSH IDM0295020

Synonyms (16)

Synonym
fk-352b
fk-352
fk 352
2-piperidineacetic acid, 1-((2e)-1-oxo-3-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-2-propenyl)-, (2r)-
(r)-1-((e)-3-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)acryloyl)-piperidin-2-ylacetic acid
h7cu6r2qex ,
unii-h7cu6r2qex
143881-08-7
2-piperidineacetic acid, 1-(1-oxo-3-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-2-propenyl)-, (r-(e))-
SCHEMBL3072324
SCHEMBL2829060
UWTYIJJJSYDUQM-QFQMRYFISA-N
fk352
2-((2r)-1-((2e)-3-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)prop-2-enoyl)piperidin-2-yl)acetic acid
2-piperidineacetic acid, 1-((2e)-1-oxo-3-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-2-propen-1-yl)-, (2r)-
(r,e)-2-(1-(3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)acryloyl)piperidin-2-yl)acetic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's4 (57.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 15.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index15.36 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (15.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (25.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]